Compugen Ltd. Total Non Current Liabilities 2011-2026 | CGEN

Annual Total Non Current Liabilities Compugen Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
39.9 M	29.5 M	4.58 M	8.37 M	8.01 M	8.62 M	5.95 M	3.26 M	2.88 M	2.56 M	2.28 M	17.1 M	9.85 M	7.79 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
39.9 M	2.28 M	10.8 M

Quarterly Total Non Current Liabilities Compugen Ltd.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	8.37 M	-	7.54 M	-	8.01 M	-	8.39 M	-	8.62 M	-	9.45 M	-	5.95 M	-	2.99 M	-	3.26 M	-	3.33 M	-	2.88 M	-	2.79 M	-	2.56 M	-	2.59 M	-	2.28 M	-	16.6 M	-	17.1 M	-	14.2 M	-	9.85 M	-	6.56 M	-	8.08 M	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
17.1 M	2.28 M	7.21 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	326 M	$ 3.71	2.77 %	$ 1.11 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Alector ALEC	165 M	$ 2.07	-15.0 %	$ 213 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	10.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	5.33 M	$ 4.22	-2.05 %	$ 300 M	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Axcella Health AXLA	26.4 M	-	-16.42 %	$ 249 M	USA
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
AVEO Pharmaceuticals AVEO	14.7 M	-	-	$ 521 M	USA
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
Apellis Pharmaceuticals APLS	289 M	$ 20.74	-1.05 %	$ 2.62 B	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Corvus Pharmaceuticals CRVS	2.31 M	$ 17.8	-2.52 %	$ 855 M	USA
Agenus AGEN	264 M	$ 3.36	0.75 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	157 M	$ 28.83	-4.63 %	$ 1.67 B	USA
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA